Subject: 610 - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Subject 610

38781. AstraZeneca is to stop research into 10 diseases to cut costs. (8th March 2010)

Authors:: Jack, Andrew
Journal:: BMJ
Issue:: Volume 340(2010)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

38782. AstraZeneca must pay €52.5m fine for anticompetitive tactics, rules European court. (10th December 2012)

Authors:: Hawkes, Nigel
Journal:: BMJ
Issue:: Volume 345(2012)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

38783. AstraZeneca pays $520m fine for off label marketing. (29th April 2010)

Authors:: Tanne, Janice Hopkins
Journal:: BMJ
Issue:: Volume 340(2010)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

38784. AstraZeneca stops paying for German doctors to attend conferences. (10th May 2011)

Authors:: Stafford, Ned
Journal:: BMJ
Issue:: Volume 342(2011)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

38785. AstraZeneca takes legal action to delay generic quetiapine in US. (15th March 2012)

Authors:: Hawkes, Nigel
Journal:: BMJ
Issue:: Volume 344(2012)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

38786. AstraZeneca to pay $198m to patients over diabetes claims. (13th August 2010)

Authors:: Tanne, Janice Hopkins
Journal:: BMJ
Issue:: Volume 341(2010)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

38787. AstraZeneca vaccine: Blood clots are "extremely rare" and benefits outweigh risks, regulators conclude. (8th April 2021)

Authors:: Mahase, Elisabeth
Journal:: BMJ
Issue:: Volume 373(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

38788. AstraZeneca's covid-19 (mis)adventure and the future of vaccine equity. (11th November 2022)

Authors:: Fortner, Robert
Journal:: BMJ
Issue:: Volume 379(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

38789. AstraZeneca's covid-19 (mis)adventure and the future of vaccine equity. (7th December 2022)

Journal:: BMJ
Issue:: Volume 379(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

38790. Astrocytes and their potential role in anti-NMDA receptor encephalitis. (June 2020)

Authors:: Ismail, Fatme Seval; Faustmann, Pedro M.
Journal:: Medical hypotheses
Issue:: Volume 139(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗